Primary cutaneous follicle centre lymphoma natural history, complications and prognosis
Primary cutaneous follicle centre lymphoma Microchapters |
Differentiating Primary cutaneous follicle centre lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Primary cutaneous follicle centre lymphoma natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Primary cutaneous follicle centre lymphoma natural history, complications and prognosis |
FDA on Primary cutaneous follicle centre lymphoma natural history, complications and prognosis |
CDC on Primary cutaneous follicle centre lymphoma natural history, complications and prognosis |
Primary cutaneous follicle centre lymphoma natural history, complications and prognosis in the news |
Blogs on Primary cutaneous follicle centre lymphoma natural history, complications and prognosis |
Directions to Hospitals Treating Splenic marginal zone lymphoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Prognosis is generally excellent, and the 5-year survival rate of patients with primary cutaneous follicle centre lymphoma is approximately 97%.
Prognosis
- Prognosis is generally excellent, and the 5-year survival rate of patients with primary cutaneous follicle centre lymphoma is approximately 97%.
- The International Extranodal Lymphoma Study Group identified three prognostic factors, that are used to assess a cutaneous lymphoma international prognostic index (CLIPI), which is prognostic of disease-free status.[1]
- Elevated LDH
- More than two skin lesions
- Nodular lesions
References
- ↑ Wilcox RA (2015). "Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management". Am. J. Hematol. 90 (1): 73–6. doi:10.1002/ajh.23863. PMID 25535037.